-
EMA accepts MAA for romosozumab in the treatment of osteoporosis
- Source: europeanpharmaceuticalreview
- 881
- February 2, 2018
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
